Condition: Crohn's Disease (CD) · Sponsor: AbbVie
This is a open-label extension (OLE) study designed to evaluate the long-term efficacy, safety, and tolerability of Upadacitinib (ABT-494).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| UC San Diego Health System /ID# 150041 | La Jolla, California, United States | — |
| Univ California, San Francisco /ID# 149987 | San Francisco, California, United States | — |
| Duplicate_University of Florida - Archer /ID# 150033 | Gainesville, Florida, United States | — |
| The Ctr for Gastro Disorders /ID# 150012 | Hollywood, Florida, United States | — |
| Nature Coast Clinical Research - Inverness /ID# 149975 | Inverness, Florida, United States | — |
| Gastroenterology Associates of Central Georgia, LLC /ID# 149870 | Macon, Georgia, United States | — |
| GI Specialists of GA, PC /ID# 150015 | Marietta, Georgia, United States | — |
| Cotton O'Neil Clinical Research Center, Digestive Health /ID# 149900 | Topeka, Kansas, United States | — |
| Duplicate_University of Louisville /ID# 149884 | Louisville, Kentucky, United States | — |
| Investigative Clinical Research /ID# 149886 | Annapolis, Maryland, United States | — |
| Charm City Research Group /ID# 150040 | Towson, Maryland, United States | — |
| Clin Res Inst of Michigan, LLC /ID# 150008 | Chesterfield, Michigan, United States | — |
+ 49 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.